The Zhitong Finance App learned that the China Securities Regulatory Commission issued the “Overseas Issuance and Listing Filing Status Form for Domestic Enterprises (Initial Public Offering and Full Circulation)”. Among them, the Hong Kong IPOs of companies such as Bangshun Pharmaceuticals are “accepted” in the China Securities Regulatory Commission.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.